...
首页> 外文期刊>Research and Science Today >OCULAR INVOLVEMENT IN MALIGNANT LYMPHOMA
【24h】

OCULAR INVOLVEMENT IN MALIGNANT LYMPHOMA

机译:恶性淋巴瘤的眼部介入

获取原文
           

摘要

THIS PAPERS AIM IS TO REVIEW AND TO SYNTHETIZE THE OCULAR INVOLVEMENT IN LYMPHOMABECAUSE THE INCIDENCE OF OCULAR LYMPHOPROLIFERATIVE DISEASES, ESPECIALLY OCULARLYMPHOMA, HAS INCREASED OVER THE LAST 20 YEARS. INSPITE OF THAT, CLASSIFICATION ANDPROPER AND DEFINITIVE TREATMENT ARE STILL CHALLENGING FOR MANY DOCTORS. A GOODCOLLABORATION BETWEEN THE OPHTHALMOLOGIST AND THE HEMATOLOGIST IS NECESSARYBECAUSE ORBITAL LYMPHOPROLIFERATIONS HAVE SPECIAL CHARACTERISTICS AND PROGNOSIS. WEALSO PRESENT 4 CASES OF LYMPHOMA -2 OF PRIMARY ORBITAL LYMPHOMA AND 2 OF NON- HODGKINLYMPHOMA. WE HAVE CHOSEN CASES OF DIFFERENT SEVERITY AND INVOLVEMENT TO HIGHLIGHTONES AGAIN THE IMPORTANCE OF DIAGNOSIS AND PROPER THERAPEUTICAL MANAGEMENT.
机译:该论文的目的是回顾和综合眼部淋巴瘤的发病情况,因为过去20年来,眼部淋巴增生性疾病(尤其是眼部淋巴瘤)的发病率有所上升。即便如此,分类,正确,权威的治疗仍然对许多医生构成挑战。眼科医师和血液学家之间的良好合作是必要的,因为轨道淋巴结增生具有特殊的特征和预后。 Wealso目前出现4例原发性眼眶淋巴瘤-2淋巴瘤和2例非霍奇金淋巴瘤。我们已经选择了不同的严重程度,并参与了重要的诊断,诊断和适当的治疗管理的案例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号